[Ocular infiltration in a patient with Multiple Myeloma].
METHODS
We report the case of a patient with Multiple Myeloma Ig G Kappa stage IIIA and hepatic infiltration, who presented with ocular infiltration. The initial sign was a rapidly growing sub-conjunctival mass that caused ophthalmoplegia and increased intraocular pressure secondary to progressive infiltration of the orbit.


CONCLUSIONS
Multiple Myeloma is a malignant tumor of plasma cells that can affect the eye and orbit, not only as an infiltration secondary to the disease but also primary as an isolated tissue proliferation (extramedullary plasmacytoma). Chemotherapy is the usual treatment given. Radiotherapy with or without excisional surgery is the first option for plasmacytomas.
Santos-Bueso
E
E
Servicio de Oftalmología, Hospital Clínico San Carlos, Madrid, Spain. enrique-santos@lycos.es
Calvo-González
C
C
Troyano
J
J
Díaz-Valle
D
D
Saiz
M
M
Benítez-del-Castillo
J M
JM
García-Sánchez
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D009798:Ocular Hypertension / Q000209:etiology; D009886:Ophthalmoplegia / Q000209:etiology; D009918:Orbital Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000970:Antineoplastic Agents